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Abstract
Transcription Activator-Like Effector Nucleases (TALEN) are potential tools for precise genome engineering of laboratory
animals. We report the first targeted genomic integration in the rat using TALENs (Transcription Activator-Like Effector
Nucleases) by homology-derived recombination (HDR). We assembled TALENs and designed a linear donor insert targeting
a pA476T mutation in the rat Glucocorticoid Receptor (Nr3c1) namely GRdim, that prevents receptor homodimerization in
the mouse. TALEN mRNA and linear double-stranded donor were microinjected into rat one-cell embryos. Overall, we
observed targeted genomic modifications in 17% of the offspring, indicating high TALEN cutting efficiency in rat zygotes.
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Introduction
Customized nucleases (Zinc Finger Nucleases, TALENs and
CRISPRs (Clustered Regularly Interspaced Short Palindromic
Repeats) [1–4]) have revolutionized the genetic engineering field.
TALENs are DNA binding nucleases that can be tailored to bind
almost any sequence. It has been reported that a TALEN cleavage
site can be found every 35 bp of genomic DNA [5]. TALENs are
versatile molecules that can be easily designed, cloned, assembled
and tested in a molecular biology laboratory. With the description
[6,7], and assembly [8,9] of TALENs, the genetic engineering field
has made important progress. Today, there are several web-
accessible software available for the design and assembly of
customized TALEN arrays. The most used are: TALE-NT or the
newest version TALE-NT 2.0 [5,10], developed by Voytas and
Bogdanove, where TALENs are assembled using the golden gate
strategy [11], and a standard cloning assembly named REAL
(Restriction Enzyme And Ligation) [12] developed in Joung’s
laboratory, that includes high throughput techniques [13]. Gene
disruption (knock-out) by TALENs has been achieved recently in
several organisms including C. elegans [14], zebrafish [15,16], mice
[17], and rat [18,19].
The rat has been historically a well suited model for health-
related research fields such as physiology [20] and behavioral
genetics [21]. However its use has been hampered due to the
difficulty of culturing embryonic stem cells (ESC) and difficult gene
manipulation techniques [22]. We report successful gene targeting
(Knock-in, KI) in the rat by TALEN mRNA microinjection in
one-cell embryos, which requires no ES cell culture and is efficient.
Results
TALEN design and assembly
Using the Zifit Targeter (Materials and Methods), we
obtained a set of 18 TALEN pairs using two query sequences
indicated in Table S1 in File S1. All TALENs targeted the
pA476T mutation in the rat glucocorticoid receptor (GR, Nr3c1)
(Fig. 1a), corresponding to the pA458T mutation in mouse, that
inhibits GR dimerization, namely GRdim [23]. Following the
guidelines for TALEN-site selection in Cermak et al. [5], we
selected 3 TALENs: TAL 3, TAL 6 and TAL 13. We assembled
the 3 TALENs into heterodimeric FokI expressing vectors
described in [24] following the REAL and REAL-Fast standard-
cloning assembly method from TALengineering.org (see Table
S1 in File S1 for detailed TALEN binding sequences).
Functional analysis of TALENs in rat C6 glioma cells
We transfected rat glioma C6 cells with all three TALEN pairs
and incubated them at 30uC during 72 hours. Western blot
indicated that both right and left TALEN monomers of the
TALEN pairs 3 and 6 were expressed (Fig. S1 in File S1).
However, the right TALEN 13 monomer was not highly expressed
in cells. We therefore proceeded with TALEN pairs 3 and 6 for
further experiments. Prior to injection in rat zygotes, we assessed
TALEN nuclease activity in C6 cells by a DNA mismatch detector
assay: T7 endonuclease I (T7 endo I). We transfected C6 cells with
either right or left TALEN monomers or both, or a GFP
expressing plasmid for transfection efficiency control. After
incubation for 72 hours, we harvested the cells and amplified
genomic DNA to obtain amplicons of 465 base pairs (bp) around
pA476 (Materials and Methods). DNA amplicons were then
denatured at high temperature and annealed to form heterodu-
plexes that were detected by the T7 endo I nuclease. Primers used
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are listed in Table S2 in File S1. Resulting bands were 177 and
288 bp long (Fig. 1b).
T7 endo I assay indicated high specific TALEN activity of 20
and 16%, for TAL 3 and TAL 6 respectively (Fig. 1b). We
continued with TAL 3. To further determine the ‘‘indels’’
(insertions and deletions) generated by TAL 3 in C6 cells, we
amplified the genomic DNA of the TAL 3-transfected C6 cells and
performed a screening of the amplified Nr3c1 gene. Screening
results indicated a rate of 22.5% of NHEJ (Non Homologous End
Joining, results not shown), which confirmed the results of the T7
endo I assay in cells. Cells transfected with TAL 3 presented
mostly deletions ranging from 1 to 16 nucleotides (Fig. 1c).
Donor molecule design and linearization
To generate GRdim KI rats, we designed a common donor
plasmid for TALENs 3 and 6, bearing the pA476T mutation along
with 4 silent point mutations in each TALEN binding site to
prevent further nuclease activity in the targeted alleles (Fig. 2 and
Fig. S2 in File S1). The donor plasmid sequence had also 500 bp
homology arms on 39 and 59 sides of the pA476T mutation, to
allow homology-derived recombination as described in [25]. The
donor carried two extra point mutations for rapid detection by
enzyme digestion: an AluI site was removed and a HaeIII site was
added close to the pA476T site (Fig. 2 and Fig. S2 in File S1).
Figure 1. TALEN design and evaluation of cutting efficiency in rat glioma C6 cells. (a) Schematic of the rat Nc3r1 (GR) gene. Zoom on the
area of the mutation pA476T in exon 3. The first nucleotide of the 476 codon is highlighted in blue. TALEN binding sites of TAL 3 are highlighted in
green. Detailed sequences of TAL 6 binding sites can be found in Table S1, File S1. (b) T-endo1 assay results. Pooled DNA from C6 cells transfected
with either Right, Left or Right and Left TALEN monomers (marked with R, L or RL, respectively) was amplified and treated with T7 endo 1 enzyme.
Cut bands of 288 and 177 bp indicate TALEN activity. Mcells are mock transfected cells, GFP: GFP transfected cells were used as a positive transfection
control. Intensity of the cut bands are indicated for TAL 3 and TAL 6 pairs. (c) TAL 3 transfected cells screening. PCR amplicons of the region around
the pA76T mutation were subcloned into TOPO vector. Clones were isolated and analyzed individualy. Four point mutations and insertion.s are
marked in red.
doi:10.1371/journal.pone.0088146.g001
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Generation of GR knockout and knockin rats by TALEN
mRNA injection in one-cell stage embryos
TALEN mRNA and excised linearized double-stranded donor
DNA containing point mutations and diagnostic restriction sites
were co-injected into fertilized one-cell stage embryos at two
concentrations (20 ng/ml or 10 ng/ml of each TALEN monomer
mRNA) and at 5 ng/ml for donor DNA. As previously described
[26] we performed a two-step microinjection procedure: we first
injected the mixture TALEN/DNA into the male pronucleus and
then into the cytoplasm during the withdrawal of the injection
pipette. Data are summarized in Table 1.
Analysis of the HR events in Fo founders by AluI and
HaeIII enzyme digestion and sequencing
To reveal homologous recombination events located in the
correct locus, we amplified the genomic DNA of the founders with
the forward primer designed outside of the homology region and
reverse primer inside of the homology region (‘‘outside-in’’) and
digested them with AluI and HaeIII enzymes. Primers used are
described in Table S2 in File S1. Gel digestion of the Nr3c1 exon
3 revealed one KI female founder (namely 3.4) from the first
injection series of higher TALEN mRNA out of 225 zygotes (KI
founder gel digestion in Fig. S3 in File S1), and thus representing
1.7% of all live born pups. Sequencing of the Nr3c1 exon 3
revealed that the 3.4 rat also presented a full donor DNA
integration by homology-derived recombination (HDR). In
addition to the KI allele, rat 3.4 also had a wild type and a 7 bp
depleted alleles of the Nr3c1 gene (Fig. 3 and Fig. S4 in File S1).
Analysis of the NHEJ events in Fo founders by AluI
enzyme digestion and sequencing
To reveal NHEJ events in other founders, we digested the Nr3c1
exon amplified with ‘‘inside-out’’ primers with AluI enzyme. Nine
NHEJ events were found resulting from both injection series
(Table 1 and Fig. S5 in File S1). Microinjection with each ratio
TALEN/DNA resulted in both cases in high embryo survival
(76% and 79% of injected embryos, respectively). All 9 founders
showed Nr3c1 deletions between 5 and 527 bp (data not shown).
Three founder rats named 11.4, 6.1 and 5.5, were heterozygous
and likely presented in-frame deletions of 6, 18 and 309 bp,
respectively (Fig. 4). These mutations correspond to deletions of
the dimerization and/or DNA-binding domain of the glucocor-
ticoid receptor. We kept these 3 rats for further breeding.
To check whether our linearized donor was integrated
elsewhere into the genome, we performed a Southern blot analysis
of all 58 founders using a hybridization probe around exon 3 and
searched for additional integration events to the 3.6 kb HincII
endogenous fragment (Fig. 5). In total, 7 live born pups out of 58
(12%) exhibited an off-target integration of the donor sequence. 5
out of 48 (10%) wild type founders and 2 out of 10 (20%) KO/KI
founders harbored randomly one or several copies of the donor
insert.
Discussion
To our knowledge, here we report the first KI rat made by
TALEN-mediated homology-derived recombination with a linear
donor. In this study, we used linear donor since in previous
injections, we were unable to obtain KI animals with a supercoiled
donor. We observed 10 targeted mutations out of 58 pups born
alive, representing 17% of the offspring. These results indicate
high TALEN efficiency. Nine of the 10 Nr3c1 gene modifications
were knockouts and 1 was a knockin. Our single KI founder 3.4
harbored three Nr3c1 alleles: KI (44%), KO (17%) and wt (39%),
as analyzed by subcloning of the amplified Nr3c1 exon 3 (results
not shown). Offspring of the KI rat 3.4 died before giving rise to
birth. NHEJ events were observed in 9 rats. Three analyzed and
bred rats transmitted the mutated allele to the next generation
confirming germline transmission. The 3 founders analyzed where
Figure 2. Donor plasmid design for the generation of GRdim KI rat. Upper DNA indicates the wild type sequence of the exon 3 of the rat
Nr3c1 GR. In blue the residue A476. TAL 3 and TAL 6 binding sites are indicated. DP, donor plasmid sequence. Donor plasmid was synthesized with
500 pb homology arms on both ends. The pA476T point mutation is highlighted in blue. Silent mutations of the DP are shown in red bold letters and
are located in the overlap of TAL 3 and Tal 6 binding sites. HaeIII site is highlighted in yellow. AluI site is not shown in this figure.
doi:10.1371/journal.pone.0088146.g002








No. NHEJ pups (% of
offspring)




40 (20+20)/5 225/171 (76) 32 (14) 4 (13) 1 (3) 16
20 (10+10)/5 293/228 (79) 27{ (9) 5 (19) 0 19
{One pup was born dead.
Two doses of TAL 3 mRNA were used (20+20 or 10+10 ng/ml of each TALEN). The egg survival rate is shown in percentage. NHEJ indicates the number of pups that had
a gene disruption event in the sequence around pA476T. The percentages were calculated within each set of TALEN mRNA amount injected.
doi:10.1371/journal.pone.0088146.t001
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heterozygous and had a deletion of several base pairs that are
likely in-frame mutations of the glucocorticoid receptor, within the
dimerization and/or DNA-binding domain. In 2 of the 3 founder
lines, we obtained homozygous mutant offspring (Sofia Verouti,
personal communication). They will be used for further physio-
logical experiments.
Seven out of 58 live born founders (representing 12% of the
offspring) presented off-site-target events. Of the 7 pups presenting
off-target events, 2 had already on-target modifications. In some
cases, off-targeted insertions were observed in up to three different
loci in the same pup.
The rate of NHEJ found in rats was predicted efficiently by our
assay in rat C6 cells and confirmed by screening (20% cutting
efficiency determined by T7 endo I assay and 22.5% NHEJ by
screening). Screening assays in cells indicated the generation of
indels ranging from 1 to 16 bp, compared to deletions ranging
from 5 to 527 bp in rats. 50% of the Nr3c1-targeted rats carried
various Nr3c1 alleles, including wild type sequences and deletions
of several nucleotides.
This report serves as a proof of concept that TALENs are
efficient tools to generate targeted and specific mutagenesis of the
rat with linear donor molecules. They are affordable, convenient,
freely designed and assembled in a molecular biology laboratory.
We demonstrate the first gene editing in the rat by homology-
derived recombination (HDR) using oocyte microinjection of
TALENs mRNA with a linear donor molecule. This report might
encourage further TALEN-mediated gene targeting in the rat to
apply these models in physiological and genetic research.
Materials and Methods
GR Nr3c1 gene sequencing
The GR sequence around the pA476 site was sequenced from
amplified genomic DNA pools of 106 rat C6 cells (CCL-107,
ATCC) and 6 adult Sprague-Dawley rats (Charles River
Laboratory SAS SD rats): 3 males and 3 females. The primers
used for the sequencing are listed in Table S2 in File S1.
TALEN design and construction
TALEN pairs were designed using the free software from the
website http://zifit.partners.org/ZiFiT/ and protocols for the
standard cloning method and REAL assembly are available at
http://www.talengineering.org/platforms-real.htm. The query
sequence for TALEN design and the TALEN binding sites are
available in Table S1 in File S1. TAL 3 was cloned by standard
cloning according to instructions in http://zifit.partners.org/
ZiFiT/Program_use.aspx#_TAL_Assembly. TAL 6 and 13
sequence were ordered for synthesis at Eurofins MWG Operon
with 59 overhang bearing the BbsI site and the 39 bearing the BsaI
site and then cloned into nuclease backbone vectors from the
REAL protocol [12].
Donor plasmid design
The donor plasmid had the pA476T site and homology arms
made of 500 bp on the 39 and 59 ends. The AluI site in intron 3
was suppressed and the silent mutation giving the HaeIII site in
exon 3 was added to test the insertion efficiency of the TALENs.
Each TALEN binding site also carried 4 extra silent point
mutations.
Cell transfection, gene amplification and DNA
preparation for the T7 endo I assay
105 rat C6 cells were cultured in F-12 GlutamaX (Invitrogen,
now Life Technologies), 10% FBS heat-inactivated and seeded in
6 well plates. Cells were transfected the next morning with
plasmids encoding for TALENs at 0.6 mg total DNA per well and
Lipofectamine 2000 (Invitrogen, now Life Technologies) following
manufacturer’s instructions. They were kept at 37uC for 4 hours in
F-12 medium without FBS and Lipofectamine 2000. Then the
medium was replaced by complete medium (F-12 and FBS), and
cells were left for 72 hours at 30uC. Then cells were harvested and
genomic DNA was extracted using Phire Animal Tissue Direct
PCR Kit (Thermo Scientific) and amplified. Primers for amplifi-
cation are listed in Table S2 in File S1. 5 ml of the PCR mix
were heated at 95uC for 10 minutes and then the temperature was
Figure 3. Founder KI female 3.4 genotyping from subcloned PCR amplicons of tail biopsies. Wt: Wild type; DP: donor plasmid. Point
mutations in the DP are indicated in red bold letters. The pA476T mutation is highlighted in blue.
doi:10.1371/journal.pone.0088146.g003
Figure 4. Fo KO rat genotyping. Wt, wild type sequence. TALEN binding sites are shown in green. The pA476T mutation is highlighted in blue.
Longer deletions are marked with double slash. Rats 11.4, 6.1 and 5.5 (underlined) were kept for breeding. All rats beared the wt allele of the Nr3c1
gene. Primers used are listed in Table S2, File S1.
doi:10.1371/journal.pone.0088146.g004
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decreased by 5uC every minute until it reached 10uC in a
Thermocycler.
T7 Endo I mismatch detection assay and cloning
1 ml of NEB Buffer 2 (New England Biolabs) and, 0.5 ml of T7
Endo I nuclease (New England Biolabs) were added to the PCR
mix previously prepared and incubated for 30 minutes at 37uC.
Samples were loaded on agarose gel with 5 times concentrated
loading buffer for analysis as described previously [26]. Amplified
DNA was cloned into blunt vector using the TOPO cloning kit
(Invitrogen, now Life Technologies) and transformed into HB101
bacteria. Colonies were seeded in 200 ml of LB medium in 96 well
plates and sequenced.
Animals
Sprague-Dawley rats (SD/Crl, Charles River) were housed in
standard cages and protocols were conducted in accordance with
the guidelines for animal experiments of the Veterinary Services
and were performed by officially authorized personnel in a
certified animal facility. All animal experiments were compliant
with the Animal Protection Law of the French republic (article R-
214-89), which is in compliance with the European Community
Council recommendations for the use of laboratory animals 86/
609/ECC, and were approved by the CEEA Pays de la Loire
committee (ref: CEEA-2011-45).
Cell lysis and Western blot analysis
C6 cells were harvested and lysed with 1% Triton buffer (1 M
Tris, 5 M NaCl, 1% Triton X-100 (Sigma), 1:500 vol/vol of the
following: leupeptin, aprotinin and pepstasin (Sigma) and 1:1000
vol/vol of PMSF (Sigma)) for 30 minutes at 4uC in a roller. Then
cell lysis was centrifuged 15 minutes at 15000 rpm to remove cell
membrane debris. The supernatant containing the proteins was
loaded on a 10% acrylamide gel with denaturing sample buffer
after incubated at 95uC for 5 minutes. Proteins were transferred to
a nitrocellulose membrane and blocked with 5% milk TBS. After
washing, the membrane was incubated with 1:1000 monoclonal
antibody against flag protein produced in mouse (Sigma) and
secondary antibody was anti-mouse IgG linked to horseradish
peroxidase (GE Healthcare). The film was exposed 5 minutes.
In vitro transcription of TALEN mRNA
For the pA476T gene targeting, TALEN-encoding expression
plasmids were linearized with PmeI. Messenger RNA was in vitro
transcribed and polyadenylated using the mMessage mMachine
T7 Ml ultra kit (Ambion) following the manufacturer protocol and
purified using the MegaClear Kit (Ambion), quantified using a
NanoDrop-1000 (Thermo Scientific) and stored at 280uC until
use. Messenger RNAs encoding pA476T TALENs were mixed to
a final total concentration of 10 ng/ml, or 20 ng/ml of each
TALEN monomer in TE 5/0.1 (5 mM Tris-Cl pH 7.5, 0.1 mM
EDTA in RNase DNase free water) and stored at280uC until use.
mRNAs were kept on ice during all micro-injection procedures.
Linearization of donor DNA
Donor plasmid for GRdim TAL 3 and TAL 6 was digested with
NotI to excise the donor DNA from the vector backbone for HDR.
After electrophoresis, digested linear donor DNA was cut from
agarose gel, electroeluted and purified with Elutip-d column
(Whatman). Linear DNA was quantified using a NanoDrop-1000
and stored at 220uC until use. Linear donor DNA was mixed at
5 ng/ml with TALENs mRNA and stored at 280uC until use.
Microinjection into rat zygotes
Prepubescent females (4–5 weeks old) were injected with 30 IU
pregnant mare serum gonadotropin (Intervet) and followed
48 hours later with 20 IU human chorionic gonadotropin
(Intervet) before breeding as previously described [27]. Fertilized
one-cell stage embryos were collected for subsequent microinjec-
tion using a previously published procedure [27]. Briefly, a
mixture of TALEN mRNA and donor DNA was microinjected
both into the male pronucleus and into the cytoplasm of fertilized
one-cell stage embryos. Two ratios of diluted TALEN mRNA and
donor DNA have been tested. Surviving embryos were implanted
on the same day in the oviduct of pseudo-pregnant females
(0.5 dpc) and allowed to develop to full term.
Rat genotyping experiments
DNA from neonates was extracted from tail biopsy following
treatment with Proteinase K. Rat tail biopsies where incubated
overnight at 55uC in 500 ml of Proteinase K solution (0.2 M NaCl,
1.1 M Tris (pH 8.3), SDS 0.2%, EDTA 5 mM and 100 mg/ml
proteinase K (Sigma)). DNA was extracted following NaCl method
by adding 6 M of NaCl, mixing and quick spin down. Supernatant
was mixed with 2/3 of the volume of isopropanol, and vortexed
for 2 minutes. Solution was centrifuged at 10000 rpm and the
supernatant was removed. DNA pellet was washed with 1.5 ml of
70% ethanol and then resuspended in bi-distilled water for 2 hours
at 37uC. Genotyping and sequencing was performed using primers
listed in Table S2 in File S1. Amplicons were digested with
either HaeIII or AluI enzymes then ran on a 1.8% agarose gel.
Southern blot
Southern blot analysis of founders following HincII digestion of
tail DNA and hybridization with a duplicated PCR-amplified exon
3 probe was performed using standard procedures. Briefly, the
exon 3 sequence was amplified by PCR using primers listed in
Table S2 in File S1 inserted in 2 concatemers into TOPO
cloning vector and isolated as an EcoRI fragment for hybridization
using standard conditions.
Supporting Information
File S1 Supplementary Data are available at PLoS ONE
Online and include Table S1–S2 and Figure S1–S5. Table
Figure 5. Detection of random donor integration in rat
founders. Representative Southern blot analysis of founder rat
genomic DNA following HincII digestion of genomic DNA and
hybridization with exon 3-derived probe. Indicated is the 3.6 kb
endogenous exon 3-containing genomic fragment and additional
random integrations in founder 5.4 (knockout) and 8.1 (wildtype) rats.
Rats 5.5 and 6.1 are knockouts as well but presented no off-target
donor integration.
doi:10.1371/journal.pone.0088146.g005
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S1: Nr3c1 sequence for TALEN design and binding site sequences.
Table S2: Primers used in this experiment. Figure S1 Evaluation of
TALEN expression in C6 rat cells. C6 cells were transfected with
either TAL 3, 6 or 13, Right (R), Left (L) or both (RL). Western
blot was performed with antibody against flag tag. Mcells are
mock-transfected cells. Figure S2 Sequence of the Nr3c1 gene
donor plasmid. The homology arms are indicated in purple, the
exons and introns of the Nr3c1 gene are indicated in orange and
black lines respectively. TALEN binding sites are indicated in blue
and the spacer in red. Nucleotides that are mutated in the donor
are marked in bold letters. HaeIII site in the donor is underlined in
blue. Suppressed AluI site (is underlined in purple). Figure S3 Gel
digestion analysis of the 3.4 rat Nr3c1 exon 3. Primer pairs used in
this experiment (‘‘outside-in’’) are shown in Table S2 in File S1.
Wt indicates expected fragments of wild type animals for both AluI
and HaeIII enzymes. The stars indicate bands expected of the
donor sequence: for AluI digestion: one upper band of 883 bp (*),
for HaeIII digestion: two bands of 524 (**) and 359 bp (***). Rat
3.4 also shows wt digestion pattern, indicating that it is
heterozygous for the pA476T mutation. Figure S4 Sequencing
of the Nr3c1 gene in 3.4 KI rat. Genomic DNA was amplified with
primers outside out the donor sequence (‘‘outside-out’’) (c. f. Table
S2 in File S1), and cloned into TOPO cloning vector. 21 clones
were selected for sequencing. Here we show 3 representative
sequences. Wt, wild type sequence; exp, expected sequence,
DNA1, clone 1, DNA2, clone 2, DNA5, clone 5. TALEN binding
sites from the donor are in green, bold letters indicate the mutated
nucleotides. HaeIII site is present in the donor sequence only; AluI
is present in the wild type sequence only. Figure S5 Gel digestion
analysis of ‘‘indels’’ in Fo founders rats. ‘‘Inside-out’’ primers were
used in this assay (Table S2 in File S1). Wt indicates expected
fragments of wild type animals upon digestion with AluI enzyme.
All pups have variable size bands on the lower molecular weight
zone, indicating possible indels. The KI rat 3.4 upper band
(marked with a * of 469 bp) indicates absence of the AluI site close
to the pA476T. KI fragment sizes expected: 125, 250 and 469 bp
Wt fragment sizes expected: 125, 175, 250 and 294 bp.
(DOCX)
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